Dr Robert Brent Hubbard, MD | |
12888 Porcupine Pass, Lava Hot Springs, ID 83246-0834 | |
(208) 776-5385 | |
(208) 776-5385 |
Full Name | Dr Robert Brent Hubbard |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 12888 Porcupine Pass, Lava Hot Springs, Idaho |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1437371812 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | M-2847 (Idaho) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Robert Brent Hubbard, MD 12888 Porcupine Pass, Lava Hot Springs, ID 83246-0834 Ph: (208) 776-5385 | Dr Robert Brent Hubbard, MD 12888 Porcupine Pass, Lava Hot Springs, ID 83246-0834 Ph: (208) 776-5385 |
News Archive
The New York Stem Cell Foundation and Q-State Biosciences are partnering in a joint research collaboration to advance patient care for nervous system disorders through precision medicine. Through this collaboration, both organizations will further advance their respective technologies, while exploring how their proprietary research platforms might provide synergies in the process of developing novel therapeutics and companion diagnostics.
A US national survey reports that even children who have had cancer previously, and are therefore at increased risk of developing further cancers, are not receiving vaccination against human papillomavirus (HPV).
A new study involving a man who swallowed worm eggs to relieve symptoms of ulcerative colitis sheds light on how worms promote healing in the intestine. The study, published today in Science Translational Medicine, also identifies potential targets for more conventional ways of treating colitis, an inflammatory bowel disease.
Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGILĀ® (armodafinil) Tablets [C-IV].
Roberta Diaz Brinton, PhD, an internationally recognized expert on Alzheimer's disease and inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has received a five-year, $1.8 million grant from the National Institutes of Health Institute on Aging.
› Verified 5 days ago